Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Sales | 74,211 | 25,142 |
| Cost of Goods | 32,506 | 16,535 |
| Gross Profit | 41,705 | 8,607 |
| Operating Expenses | 73,545 | 58,710 |
| Operating Income | -31,334 | -49,568 |
| Interest Expense | 401 | 2,078 |
| Other Income | 2,581 | 4,586 |
| Pre-tax Income | -29,154 | -47,060 |
| Income Tax | 665 | 13 |
| Net Income Continuous | -29,819 | -47,073 |
| Net Income | $-29,819 | $-47,073 |
| EPS Basic Total Ops | -2.58 | -4.40 |
| EPS Basic Continuous Ops | -2.58 | -4.47 |
| EPS Diluted Total Ops | -2.58 | -4.60 |
| EPS Diluted Continuous Ops | -2.58 | -3.96 |
| EBITDA(a) | $-27,399 | $-48,185 |